Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Limiting Secondary Damage of Brain Injury

By HospiMedica staff writers
Posted on 20 May 2002
A new study will seek to determine whether cyclosporin A, a chemotherapy drug, can limit some of the secondary damage, such as swelling, that occurs in patients with severe traumatic brain injury.

Researchers at the University of Florida (Gainesville, FL, US) theorize that head injury damages nerve cells in the brain, which renders them less able to regulate the flow of chemicals, especially calcium, in and out of the cells. More...
A buildup of calcium inside the cell causes progressive damage to the mitochondria and finally kills the nerve cells. By treating the victims of severe brain injury within 12 hours with cyclosporin A, the researchers hope to prevent this delayed response that causes cell death. They say the new treatment may also be effective for stroke, hemorrhage, and tumors.

In animal studies, a low dose of the drug was shown to regulate the flow of calcium into cells, thereby preventing injury to mitochrondia. The drug will be administered through an intravenous catheter to patients who arrive at the hospital within eight hours of the injury. Brain levels will be evaluated through a catheter inserted parallel to the tube routinely used to measure pressure inside the brain. The catheter will also be used to sample substances from the brain to determine whether they contain breakdown products indicative of nerve cell death.

"We're trying to separate the events associated with head injury that are primary—meaning they're a product of the injury itself—from the reactions or misdirected healing attempts by the body that end up being more destructive than the actual injury,” said A. Joseph Layon, M.D., professor of critical care medicine in the department of anesthesiology, who is directing the study.




Related Links:
Univ. of Florida

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Patient Monitoring System
AlarmSense
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The device combines a minimally invasive, long‑lifetime “read/write” brain‑computer interface (BCI) with assistive devices and AI-driven support (photo courtesy of Epia Neuro)

Implantable Brain-Computer Interface Supports Stroke Recovery and Assistive Function

Stroke leaves many survivors with chronic motor deficits that limit independence, and cognitive decline is a growing concern in aging populations. Stroke is a leading cause of long-term disability in the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.